Valuation: Revvity, Inc.

Capitalization 11.1B 9.47B 8.68B 8.22B 15.23B 1,063B 15.38B 103B 40.28B 504B 41.66B 40.78B 1,751B P/E ratio 2026 *
39.1x
P/E ratio 2027 * 32x
Enterprise value 12.72B 10.85B 9.95B 9.42B 17.45B 1,217B 17.62B 118B 46.14B 577B 47.72B 46.71B 2,006B EV / Sales 2026 *
4.47x
EV / Sales 2027 * 4.04x
Free-Float
99.66%
Yield 2026 *
0.28%
Yield 2027 * 0.28%
1 day+0.35%
1 week+7.58%
Current month+14.64%
1 month+10.59%
3 months+3.90%
6 months+5.49%
Current year+2.64%
1 week 94.6
Extreme 94.6
103
1 month 81.22
Extreme 81.22
103
Current year 81.22
Extreme 81.22
118.3
1 year 81.22
Extreme 81.22
118.3
3 years 79.5
Extreme 79.5
131.96
5 years 79.5
Extreme 79.5
203.16
10 years 45.35
Extreme 45.35
203.16
Manager TitleAgeSince
Chief Executive Officer 61 30/12/2019
Director of Finance/CFO 37 06/09/2022
Chief Tech/Sci/R&D Officer - 01/05/2023
Director TitleAgeSince
Chairman 68 30/12/2019
Director/Board Member 74 07/02/2012
Director/Board Member 72 27/07/2016
Change 5d. change 1-year change 3-years change Capi.($)
+0.35%+7.58%+0.81%-14.62% 11.1B
+1.48%-1.60%+6.17%-12.46% 171B
+2.81%-4.32%-23.08%+41.47% 153B
-0.16%-4.79%-17.21%-26.87% 118B
+1.37%-3.36%-47.41%+1.42% 80.41B
+3.32%-3.84%+6.59%-10.60% 45.91B
-0.35%-4.91%-31.07%-38.21% 44.35B
+1.19%+2.76%-3.94%+29.97% 34.57B
+1.29%-3.94%-2.29%-11.44% 31.91B
-1.67%-1.19%-27.39%-45.76% 29.63B
Average +0.53%-1.86%-13.88%-8.71% 71.92B
Weighted average by Cap. +0.76%-3.01%-14.46%-2.58%

Financials

2026 *2027 *
Net sales 2.84B 2.43B 2.22B 2.11B 3.9B 272B 3.94B 26.5B 10.32B 129B 10.67B 10.45B 449B 2.99B 2.55B 2.34B 2.21B 4.1B 286B 4.14B 27.87B 10.85B 136B 11.23B 10.99B 472B
Net income 281M 240M 220M 208M 386M 26.9B 389M 2.62B 1.02B 12.76B 1.05B 1.03B 44.33B 330M 281M 258M 244M 453M 31.58B 457M 3.07B 1.2B 14.98B 1.24B 1.21B 52.04B
Net Debt 1.61B 1.38B 1.26B 1.2B 2.22B 155B 2.24B 15.04B 5.86B 73.31B 6.06B 5.93B 255B 973M 830M 761M 721M 1.34B 93.15B 1.35B 9.07B 3.53B 44.18B 3.65B 3.57B 154B
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
12/05/26 99.30 $ +0.35% 1,328,927
11/05/26 98.95 $ -2.03% 1,600,921
08/05/26 101.00 $ +2.18% 2,441,940
07/05/26 98.85 $ -0.24% 2,004,990
06/05/26 99.09 $ +7.36% 3,014,201
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
99.30USD
Average target price
113.64USD
Spread / Average Target
+14.44%

Quarterly revenue - Rate of surprise